Together, our data suggest that fluoxetine protects from impairment of glucose oxidation in the septic heart and cardiac ectopic lipid accumulation, and this is dependent on IL-10 protection against hypertriglyceridemia (Fig. 7O). The gene discussed is IL10; the disease is hypertriglyceridemia.